PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 6/30
$0.34+0.00 (+0.53%)
Close on Oct 19, 2026Market cap $3.67MP/E –Yield –
PharmaCyte Biotech free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
No free cash flow figures for PharmaCyte Biotech
PharmaCyte Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?